Denis Chem Lab Ltd - Stock Valuation and Financial Performance

BSE: 537536 | NSE: | Pharmaceuticals & Drugs | Small Cap

Denis Chem Lab Share Price

181.20 16.90 10.29%
as on 20-Dec'24 16:59

DeciZen - make an informed investing decision on Denis Chem Lab

Overall Rating
M-Cap below 500cr. High Risk from low Liquidity Bole Toh

1. Quality

2. Valuation

Somewhat overvalued

3. Price Trend

Denis Chem Lab stock performance -

mw4me loader
P/E Ratio (SA):
21.79
Market Cap:
251.5 Cr.
52-wk low:
108.1
52-wk high:
232.9

Is Denis Chem Lab Ltd an attractive stock to invest in?

1. Is Denis Chem Lab Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Denis Chem Lab Ltd is a average quality company.

2. Is Denis Chem Lab Ltd undervalued or overvalued?

The key valuation ratios of Denis Chem Lab Ltd's currently when compared to its past seem to suggest it is in the Somewhat overvalued zone.

3. Is Denis Chem Lab Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Denis Chem Lab Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Denis Chem Lab:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Denis Chem Lab Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Value Creation Index Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
ROCE % 10.9%5.3%12.2%9.4%11.9%11.3%6.5%13.8%16.1%20.2%-
Value Creation
Index
-0.2-0.6-0.1-0.3-0.2-0.2-0.50.00.20.4-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 76.999.6113107124136109137161168169
Sales YoY Gr.-29.7%13.8%-5.4%15.8%9.7%-19.7%24.9%17.8%4.3%-
Adj EPS 0.1-4.70.91.64.131.64.55.788.3
YoY Gr.--5322.2%NA80.2%149.4%-25.9%-45.9%174.4%25.8%42.1%-
BVPS (₹) 17.71324.13640.742.644.347.952.157.959.4
Adj Net
Profit
0.1-4.51.12.35.74.22.36.37.911.212
Cash Flow from Ops. 14.220.96.810.6813.4817.116.317.6-
Debt/CF from Ops. 3.42.15.52.42.911.10.20.10.1-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 9.1%6.2%15.4%4.3%
Adj EPS 64.7%14.5%69.9%42.1%
BVPS14.1%7.3%9.3%11.2%
Share Price 17.1% 39% 41.3% 54.7%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
Return on
Equity %
0.7-274.95.710.77.33.89.811.314.614.2
Op. Profit
Mgn %
12.18.512.311.411.2119.410.511.712.712.6
Net Profit
Mgn %
0.1-4.512.14.63.12.14.64.96.76.8
Debt to
Equity
2.83.51.30.50.40.20.10.1000
Working Cap
Days
15612211414613913115712310310076
Cash Conv.
Cycle
7346243653668059444045

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 14.20%

Sales growth is growing at healthy rate in last 3 years 15.36%

Net Profit is growing at healthy rate in last 3 years 69.88%

Sales growth is not so good in last 4 quarters at 2.50%

Latest Financials - Denis Chem Lab Ltd.

Standalone Consolidated
TTM EPS (₹) 8.3 -
TTM Sales (₹ Cr.) 169 -
BVPS (₹.) 59.4 -
Reserves (₹ Cr.) 72 -
P/BV 3.05 -
PE 21.79 -
From the Market
52 Week Low / High (₹) 108.10 / 232.90
All Time Low / High (₹) 16.26 / 232.90
Market Cap (₹ Cr.) 251
Equity (₹ Cr.) 13.9
Face Value (₹) 10
Industry PE 44.3

Management X-Ray of Denis Chem Lab:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Denis Chem Lab

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Sales77100113107124136109137161168
Operating Expenses 6891999511012199122142147
Manufacturing Costs681010111410121515
Material Costs36525349616255728487
Employee Cost 79139121211121314
Other Costs 18212427253323262930
Operating Profit 981412141510141921
Operating Profit Margin (%) 12.1%8.5%12.3%11.2%11.2%11.0%9.4%10.5%11.7%12.7%
Other Income 0011200111
Interest 5765332111
Depreciation 4676676687
Exceptional Items 0000000000
Profit Before Tax 0-32266391115
Tax 0110021334
Profit After Tax 0-4126426811
PAT Margin (%) 0.1%-4.5%1.1%2.0%5.1%3.1%2.1%4.6%4.9%6.6%
Adjusted EPS (₹)0.1-4.71.01.54.63.01.64.55.78.0
Dividend Payout Ratio (%)0%0%0%0%22%0%46%33%35%31%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24

Equity and Liabilities

Shareholders Fund 17123050565962667280
Share Capital 991214141414141414
Reserves 831836434548535866
Minority Interest0000000000
Debt4136332119118211
Long Term Debt2420179524210
Short Term Debt171616131485000
Trade Payables8172020171816201821
Others Liabilities 1619111013107887
Total Liabilities 81859410110697929699109

Fixed Assets

Gross Block59627475929495101102111
Accumulated Depreciation17222935414854596774
Net Fixed Assets42404440504641423538
CWIP 01015000020
Investments 0000000000
Inventories465789910910
Trade Receivables25233231363533323132
Cash Equivalents 2371164591725
Others Assets8457544455
Total Assets 81859410110697929699109

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Cash Flow From Operating Activity 14217118138171618
PBT 0-32266391115
Adjustment 9131210897686
Changes in Working Capital 512-7-1-50-23-01
Tax Paid 0000-1-2-1-1-2-4
Cash Flow From Investing Activity -28-13-1-16-2-2-1-10-11-15
Capex -29-13-2-8-9-2-2-5-5-7
Net Investments 001-8600-5-7-9
Others 0000000001
Cash Flow From Financing Activity 13-701-5-14-6-7-4-4
Net Proceeds from Shares 601618000000
Net Proceeds from Borrowing 7-4-7-12-4-30-1-10
Interest Paid -5-7-6-5-3-3-2-1-1-1
Dividend Paid 00000-20-1-2-3
Others 54-402-6-4-400
Net Cash Flow -115-41-3101-1
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Ratios
ROE (%)0.62-30.415.865.3711.947.293.769.7911.3314.62
ROCE (%)10.935.312.199.3711.911.346.513.7916.0720.15
Asset Turnover Ratio1.21.251.321.111.21.341.151.451.641.61
PAT to CFO Conversion(x)N/AN/A75.51.333.2542.8321.64
Working Capital Days
Receivable Days9684841069895113867268
Inventory Days17171721232329252221
Payable Days6688126150111105112898283

Denis Chem Lab Ltd Stock News

Denis Chem Lab Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Denis Chem Lab on 20-Dec-2024 16:59 is ₹181.2.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 20-Dec-2024 16:59 the market cap of Denis Chem Lab stood at ₹251.4.
The latest P/E ratio of Denis Chem Lab as of 20-Dec-2024 16:59 is 21.79.
The latest P/B ratio of Denis Chem Lab as of 20-Dec-2024 16:59 is 3.05.
The 52-week high of Denis Chem Lab is ₹232.9 and the 52-week low is ₹108.1.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Denis Chem Lab is ₹169.0 ( Cr.) .

About Denis Chem Lab Ltd

Denis Chem Lab is a Public Limited Pharmaceutical Company incorporated in 1982. It started commercial production for sterile Intravenous injectibles in 1984. Since more than 30 years it has been actively delivering high quality sterile Intravenous injectibles and contributing in saving lives. It Manufactures and market sterile Intravenous injectibles in Both Glass and Plastic Bottles.

The company’s manufacturing facilities are located in a pollution free environment near Ahmedabad, Gujarat. The Manufacturing facilities are located on a land area of about 14000 sq. metres, the built up area for the manufacturing operations is about 7000 sq.m.

Its manufacturing facilities have been approved by the Foods and Drugs Control Administration Authority (FDCA), Gujarat & WHO GMP. It has also been approved by international bodies, includes FDCA Ivory Cost, Ministry of Health-Vietnam, Ministry of Health-Combodia.

Business area of the company

The company is engaged in the business of manufacturing of Pharmaceuticals Transfusion Solution in Bottles. It offers wide range of sterile intravenous injectables for human and veterinary consumption. The company’s product offerings comprise of various products sold across several states in India. It also exports sterile intravenous medicines to countries like Sri Lanka, Nepal, Combodia, Vietnam, Somalia, Ivory Cost etc. In addition to manufacturing its own products which it sells under its own brands, it does manufacture products on contract basis for third parties including certain multinational pharmaceutical companies who market such products under their own brands.

Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.